Tag: boost
COVID antibody drugs from Lilly and Regeneron won’t do much to...
When Eli Lilly won emergency use authorization for its COVID-19 antibody drug, bamlanivimab, earlier this week, beating Regeneron to the finish line in a...
AstraZeneca’s Brilinta won its coveted stroke-prevention nod. Will it be enough...
A few months ago, AstraZeneca’s Brilinta added a new U.S. indication to reduce the chance of a first heart attack or stroke in certain...
Israel’s Mapi Pharma sets aside manufacturing space to boost country’s COVID-19...
With the end of the year fast approaching, nations are looking for ways to secure enough supply of a potential COVID-19 vaccine to meet...
Oxford Biomedica earns U.K. nod for 4th manufacturing suite to boost...
Among the contract manufacturers enjoined in the race for a COVID-19 vaccine, Oxford Biomedica has forged a close relationship with AstraZeneca given its choice...
AstraZeneca eyes less-frequent Imfinzi dosing with FDA ‘priority’ boost
Merck’s Keytruda recently became the only member of the PD-1/PD-L1 class with an FDA nod for less-frequent dosing—but AstraZeneca doesn’t intend to let it...
ASCO: AstraZeneca’s Tagrisso, headed for big sales boost, cuts lung cancer...
In mid-April, at the recommendation of an independent data monitoring committee, AstraZeneca unblinded a phase 3 trial of Tagrisso two years early. Now, the...